IGH, 14q32.33, Green
MYEOV, 11q13.3, Red
The IGH/MYEOV Plus product contains IGH and MYEOV probe mixes. The IGH mix comprises three green-labelled probes: a 393 kb probe centromeric to the IGH constant region and two probes (324 kb and 289 kb) located within the IGH variable region. The MYEOV mix comprises two red-labelled probes: a 155 kb probe centromeric to MYEOV containing the TPCN2 gene, and a 162 kb probe telomeric to MYEOV containing the CCND1 and ORAOV1 genes.
Microscope image
The MYEOV (myeloma overexpressed) and CCND1 (cyclin D1) genes are located at chromosome band 11q13.3 and the IGH (immunoglobulin heavy locus) at 14q32.33. Rearrangements involving the IGH locus and the 11q13 region containing CCND1 and MYEOV occur in multiple myeloma (MM) and certain non-Hodgkin lymphomas (NHL), particularly mantle cell lymphoma (MCL).¹,²
The t(11;14)(q13;q32) translocation is one of the most common rearrangements involving these loci.¹
Rearrangements involving the IGH locus and the 11q13.3 region result in juxtaposition of IGH with CCND1 in MCL and/or MYEOV in MM.³˒⁴
In MM, t(11;14)(q13;q32) is the most common primary IGH translocation and is reported in approximately 15-20% of cases¹ and results in IGH::MYEOV gene fusion. In MCL, IGH::CCND1 is the characteristic genetic abnormality.²
The CytoCell® IGH/MYEOV Plus Translocation, Dual Fusion Probe is a qualitative, non-automated, fluorescence in situ hybridisation (FISH) test used to detect chromosomal rearrangements between the 11q13.3 region on chromosome 11 and the 14q32.33 region on chromosome 14 in Carnoy’s solution (3:1 methanol/acetic acid) fixed haematologically-derived cell suspensions from patients with confirmed or suspected non-Hodgkin lymphoma (NHL) or multiple myeloma (MM).
This product is designed as an adjunct to other clinical and histopathological tests in recognised diagnostic and clinical care pathways, where knowledge of IGH::MYEOV/CCND1 translocation status would be important for clinical management.
This device is designed to detect rearrangements with breakpoints in the regions bounded by the red and green clones in this probe set, which include the IGH, MYEOV and CCND1 genes.
Breakpoints outside these regions or variant rearrangements wholly contained within these regions, such as insertions, may not be detected with this product.
This device is not intended for: use as a stand-alone diagnostic, use as a companion diagnostic, prenatal testing, population-based screening, near-patient testing, or self-testing.
This device has not been validated for sample types, disease types, or purposes outside of those stated in the intended purpose.
It is intended as an adjunct to other diagnostic laboratory tests and therapeutic action should not be initiated on the basis of the FISH result alone.
Reporting and interpretation of FISH results should be performed by suitably qualified staff, consistent with professional standards of practice, and should take into consideration other relevant test results, clinical and diagnostic information.
This device is intended for laboratory professional use only.
Failure to adhere to the protocol may affect the performance and lead to false positive/negative results.
Find certificate of analysis documentation for our CytoCell FISH probes
Our lab has been using a wide range of CytoCell FISH probes for a number of years, and have been increasing this range all the time. The probes have clear bright signals and show good reproducibility. CytoCell provides fast delivery of catalogue probes, and are very responsive when we have any queries or problems with their products.
Bridget Manasse
Addenbrookes Hospital, Cambridge University Hosiptals NHS Foundation Trust, UK
In our hands, CytoCell FISH probes have proven to be of the highest quality with bright, easy to interpret signals, thus providing confidence in our results. OGT's customer support is outstanding, as their staff are extremely knowledgeable and truly care about their customers and their customers’ needs.
Jennie Thurston
Director of Cytogenetics, Carolinas Pathology Group, USA
I first came across CytoCell FISH probes in a previous lab I worked in and I was struck by the quality of the products. Since this time, I have been recommending and introducing CytoCell probes across all application areas — now they are the primary FISH probes used in our lab. They have an excellent range of products and their ready-to-use reagent format saves considerable time.
Elizabeth Benner
Medical Technologist, University of Arizona Health Network, USA
We have been working with CytoCell fish probes for two decades because of their excellent clarity and intensity regardless of the size of the probe. It is so clear and simple to detect.
Dr. Marina Djurisic
Head of Laboratory of Medical Genetics, Mother and Child Health Care Institute of Serbia “Dr Vukan Cupic”, Serbia
The quality and consistency of CytoCell’s probes means I can trust the results, and my clients get their results in a timely manner.
Dr. Theresa C. Brown
Director, Cytogenetics Laboratory, Hayward Genetics Center, Tulane University School of Medicine, USA
It was very important for us to have more consistent results with our probes — easy-to-read bright signals and a range of vial sizes, which is much more cost-effective.
Janet Cowan, PhD
Director of the Cytogenetics Laboratory, Tufts Medical Center, USA
Not only do CytoCell offer an extensive range of high-quality FISH probes, the customer support is also excellent — providing fast access to all the probes I need. The probes are highly consistent with bright signals allowing easy scoring of results.
Dr. Eric Crawford
Senior Director, Genetics Associates Inc., USA
The quality and reproducibility of results using the CytoCell kit has been vital in accurately detecting co-deletions in our glioma investigations. We now have a cost-effective test that we can rely on that is also easy to use and interpret. We've been consistently impressed with this kit - not to mention the support offered by OGT's customer service, and have completely transitioned over to CytoCell probes.
Gavin Cuthbert, FRCPath
Head of Cancer Cytogenetics, Northern Genetics Servce, Newcastle, UK
Visit USA site
Visit Canada site
